Mounjaro® (tirzepatide) 2.5 mg Pen – A dual GIP and GLP-1 receptor agonist indicated to improve glycemic control in adults with type 2 diabetes. Administered once weekly via a pre-filled, single-dose injection pen, starting at 2.5 mg for initial therapy before dose escalation.





Reviews
There are no reviews yet.